Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level

por Todesco, B., Ostuzzi, G., Barbui, C.
Publicado 2022

Esketamine clinical trials: reply to Maju et al.

por Gastaldon, C., Papola, D., Ostuzzi, G., Barbui, C.
Publicado 2020

Esketamine for treatment resistant depression: a trick of smoke and mirrors?

por Gastaldon, C., Papola, D., Ostuzzi, G., Barbui, C.
Publicado 2019

Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries

por Ostuzzi, Giovanni, Gastaldon, Chiara, Papola, Davide, Barbui, Corrado
Publicado 2022

Safety of psychotropic medications in people with COVID-19

por Ostuzzi, G., Papola, D., Gastaldon, C., Barbui, C.
Publicado 2021

Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries

por Ostuzzi, Giovanni, Gastaldon, Chiara, Petrini, Carlo, Godman, Brian, Barbui, Corrado
Publicado 2020

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations

por Todesco, Beatrice, Ostuzzi, Giovanni, Gastaldon, Chiara, Papola, Davide, Barbui, Corrado
Publicado 2023

Crossroads of methodological choices in research synthesis: insights from two network meta-analyses on preventing relapse in schizophrenia

por Ostuzzi, Giovanni, Schneider-Thoma, Johannes, Tedeschi, Federico, Leucht, Stefan, Barbui, Corrado
Publicado 2023

Can We Identify the Active Ingredients of Behaviour Change Interventions for Coronary Heart Disease Patients? A Systematic Review and Meta-Analysis

por Goodwin, Laura, Ostuzzi, Giovanni, Khan, Nadia, Hotopf, Matthew H., Moss-Morris, Rona
Publicado 2016

Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies

por Turrini, Giulia, Purgato, Marianna, Ballette, Francesca, Nosè, Michela, Ostuzzi, Giovanni, Barbui, Corrado
Publicado 2017

Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval

por Barbui, Corrado, Bighelli, Irene, Carrà, Giuseppe, Castellazzi, Mariasole, Lucii, Claudio, Martinotti, Giovanni, Nosè, Michela, Ostuzzi, Giovanni
Publicado 2016

Mapping the evidence on pharmacological interventions for non-affective psychosis in humanitarian non-specialised settings: a UNHCR clinical guidance

por Ostuzzi, Giovanni, Barbui, Corrado, Hanlon, Charlotte, Chatterjee, Sudipto, Eaton, Julian, Jones, Lynne, Silove, Derrick, Ventevogel, Peter
Publicado 2017

Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches

por Ostuzzi, Giovanni, Gastaldon, Chiara, Papola, Davide, Fagiolini, Andrea, Dursun, Serdar, Taylor, David, Correll, Christoph U., Barbui, Corrado
Publicado 2020

P.0493 COVID-19 related perceived stress in patients with rheumatic diseases: an Italian cross-sectional study

por Posio, C., Ingegnoli, F., Buoli, M., Di Taranto, R., Cumbo, E., Lo Muscio, A., Ostuzzi, S., Caporali, R.
Publicado 2021

COVID-19 related poor mental health and sleep disorders in rheumatic patients: a citizen science project

por Ingegnoli, Francesca, Buoli, Massimiliano, Posio, Cristina, Di Taranto, Raffaele, Lo Muscio, Alessandro, Cumbo, Enrico, Ostuzzi, Silvia, Caporali, Roberto
Publicado 2021

Pharmacovigilance analysis of the Vigibase on neonatal withdrawal syndrome following in utero exposure to antidepressants

por Gastaldon, C., Arzenton, E., Raschi, E., Spigset, O., Papola, D., Ostuzzi, G., Moretti, U., Trifirò, G., Barbui, C., Schoretsanitis, G.
Publicado 2023

Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database

por Gastaldon, C., Arzenton, E., Raschi, E., Spigset, O., Papola, D., Ostuzzi, G., Moretti, U., Trifirò, G., Barbui, C., Schoretsanitis, G.
Publicado 2023

Which psychotherapy is effective in panic disorder? Findings and reflections from a systematic network meta-analysis

por Papola, D., Ostuzzi, G., Gastaldon, C., Purgato, M., Giovane, C. Del, Pompoli, A., Karyotaki, E., Sijbrandij, M., Furukawa, T., Cuijpers, P., Barbui, C.
Publicado 2021

Pharmacovigilance analysis of the Vigibase on antidepressants-related withdrawal syndrome in adults and adolescents

por Gastaldon, C., Schoretsanitis, G., Arzenton, E., Raschi, E., Papola, D., Ostuzzi, G., Moretti, U., Seifritz, E., Kane, J. M., Trifirò, G., Barbui, C.
Publicado 2023

Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database

por Gastaldon, Chiara, Schoretsanitis, Georgios, Arzenton, Elena, Raschi, Emanuel, Papola, Davide, Ostuzzi, Giovanni, Moretti, Ugo, Seifritz, Erich, Kane, John M., Trifirò, Gianluca, Barbui, Corrado
Publicado 2022